Benitec Biopharma Inc. · NASDAQ:BNTC
Nantahala Capital Management, LLC's stake in Benitec Biopharma Inc. fell to 4.39% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Nantahala Capital Management, LLC's stake in Benitec Biopharma Inc. fell to 4.39%, 1,038,371 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 4.39%
- Shares
- 1,038,371
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 4.39% | 1,038,371 |
| Wilmot B. Harkey | 4.39% | 1,038,371 |
| Daniel Mack | 4.39% | 1,038,371 |
Source
Related
- Benitec Biopharma Inc.
- Nantahala Capital Management, LLC
- Benitec Biopharma Inc. shareholders
- Form 4 · Buchi J Kevin · Jun 30, 2026
- Schedule 13G/A · Franklin Resources Inc · Jan 29, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Dec 8, 2025
- Schedule 13G · Ra Capital Management, L.P. · Dec 3, 2025
- Schedule 13D/A · Montanova Capital, LLC · Nov 10, 2025